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Abstract
Lidocaine is one of the local anesthetics agents that are frequently used in dentistry.  Streptococcus mutan is
a gram-positive, facultatively an aerobic bacterium commonly found in human oral cavity. The study aims to
find out the effects of Lidocaine concentration against Streptococcus mutans bacteria. The study used
experimental design with liquid and solid dilution method to find out bacteriostatic and bacteriocidal effects
of Lidocaine concentration. The test bacteria used in the study are the ones, which have been compared with
Mcfarland standard solution with 10µCFU/ML concentration. The Lidocaine concentrations were 2%, 1%,
0.5%, 0.25%, 0.125%, 0.0625%, 0.03125%, 0.015625%, and 0.007812%. Kruskal-Wallis and Mann-Whitney
methods were used for the statistical test. The result of the study suggests that Lidocaine concentration has
effects against Streptococcus mutans bacteria in the concentrations of 2%, 1% and 0.5%, to inhibit bacterial
growth (p<0.05), but there was no bacteriocidal potential of Lidocaine concentration against Streptococcus
mutans bacteria (p>0.05).
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 1. Introduction
Local anesthetics have some contents in its
preparation, one of which is anesthetics agent. An
example of the agent is Lidocaine. Due to its
beneficial characteristics, Lidocaine is commonly
used in dentistry at present.
Meanwhile, awareness towards the danger of
contamination like infection, which can be
transmitted through direct contact with blood, saliva
and contaminated instruments has been growing up.
Human oral cavity is basically not free from germs.
Streptococcus mutans is one of the normal germs in
the human body. A germ can be said as normal if it is
not harmful to human body.  Streptococcus mutans
can be harmful germs for human body if the number
of harmful and beneficial germs in the human body
is imbalanced.
Antibacterial power is the power of agents which
inhibits and kills the growth of germs.  Proper
anesthetics agent is the one which has antibacterial
power, no matter how small it is. Administration of
anesthetics agent with anti-bacterial power in dental
and oral treatment serves as a preventive treatment
for the possible infection and bacteremia.
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2. Methods
This study used laboratory-based experiment
method. The subjects of the study were standard
Streptococcus mutans bacteria available in the
Microbiology Laboratory of The Faculty of Medicine,
Muhammadiyah University, Yogyakarta. Lidocaine in
2% concentration was provided by Oral and
Maxillofacial Surgery Laboratory of the Faculty of
Dentistry, Gadjah Mada University taken from a
certain trademark which is commercially available.
The independent variable during the study was
Lidocaine concentration, whereas the independent
variable was bacteriostatic potential and/or
bacteriocidal potential against Streptococcus mutans
in the Trypticase Soy Agar (TSA) as the media.
The study used two methods; finding Lidocaine
concentration with bacteriostatic potential against
the growth of Streptococcus mutans bacteria using
liquid dilution method, and finding Lidocaine
concentration with bactericidal potential against
Streptococcus mutans bacteria using solid dilution
method.
The collected data was analyzed by Kruskal-Wallis
and Mann-Whitney Test.
3. Results
Table 1 indicates that 2% and 1% Lidocaine
concentrations have bacteristatic potential against
Streptococcus mutans bacteria. The 0.5%
concentration was the border line between the
concentration with inhibiting power and the one
without, as suggested by 3 times repetition with 2
results indicating bacteriostatic potential. The lower
concentration than 0.25% indicates that there was
no effect on the bacterial growth inhibition against
Streptococcus mutans. The baceriocidal effect was
only found once within 3 times repetition which
refers to 2% concentration.
The Kruskal-Wallis analysis on Table 2 suggests
that there was a difference among various Lidocaine
concentrations towards inhibiting potential against
Streptococcus Mutans (p<0.050).  Thus, it can be
concluded that various Lidocaine concentrations
have effects to bacteristatic potential against
Streptococcus mutans.
Table 1. Bacteriostatic and bacteriocidal effects of
Lidocaine against Streptococcus mutans.
Table 2.  Summary of the statistical test on various
Lidocaine concentrations as bacteriostatic agent
against Streptococcus mutans.
Concentration Bacteriostatic Concentration Bacteriocidal
(%) (Σ) (%) (Σ)
+ - + -
2 3 0 2 1 2
1 3 0 1 0 3
0.5 2 1 0.5 0 3
0.25 0 3 0.25 0 3
0.125 0 3 0.125 0 3
0.0625 0 3 0.0625 0 3
0.03125 0 3 0.03125 0 3
0.015625 0 3 0.015625 0 3
0.007812 0 3 0.007812 0 3
(+) indicates that test concentration has both bacteriostatic/
bacteriocidal effects
(-) indicates that test concentration has no bacteriostatic/
bacteriocidal effects
Σ Bacteristatic/ bacteriocidal effects were results of 3 times
repetition
Table 3 shows the results on the differences between
two Lidocaine concentrations as bacteriostatic agent
againts Streptococcus mutans by Mann-Whitney Test.
A significant difference was obtained by 2% -
0.25% concentration and 1% - 0.25% concentration,
meanwhile no significant difference was found in 2%
- 1% concentration , 2% - 0.5% concentration , 1% -
0.5% concentration, and 0.5% - 0.25% concentration.
This finding suggests that significant difference
between two test concentrations will generate
different effects to inhibiting the growth of
Streptococcus mutans, whereas no significant
Concentration % P*
2 1 0.5 0.25 0.003
* Significance value based on Kruskal-Wallis Test.
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difference indicates that two test concentrations
generate the same effects to inhibiting potential
against the growth of Streptococcus mutans.
Table 3. Analysis-based summary of comparison
between two Lidocaine concentrations towards
inhibiting power against Streptococcus Mutans.
media, meanwhile  the negative control contains
residue of dilution. All positive controls resulted (+)
by 3 times repetition, which suggested that
Streptococcus mutans - containing positive control
remains potential to inhibit bacterial growth. The
negative control also resulted (-) during by 3 times
repetition indicating that Lidocaine may able to act
as anti-bacterial agent.
Comparative test between two Lidocaine
concentrations tested against Streptococcus mutans
suggests that the administration of 2%, 1% and 0.5%
concentration will bring the same bacteriostatic
effects against the growth of Streptococcus mutans,
whereas 0.25% concentration will generate different
effects from the 3 higher concentrations as it has no
inhibiting potential against the growth of
Streptococcus mutans.
The result of the study indicates that Lidocaine
has anti-bacterial potential against Streptococcus
mutans with its capability of inhibiting the growth of
bacteria (bacteriostatic). The result corresponds to
another study¹ which states that Lidocaine has anti-
bacterial effect with bacteriostatic characteristic
against test bacteria¹, and is supported by a study
conducted by Gajraj et al.2 which suggest that
Lidocaine has anti-bacterial power against 2 test
bacteria when it is mixed with Diprivan. Lidocaine,
however, is less potential compared to Procaine and
Prilocaine.
The mechanism of anti-bacterial potential of local
anesthetics agent has not been clearly known so far,
but there are two possible mechanisms to explain
the phenomena; first, mechanism of agent’s effect
towards structure or function of membrane, and
second, mechanism of pH alteration of bacterial
cells², which is supported by the study done by Kaya
et al.1 suggesting that effects of Lidocaine’s inhibiting
power represented by synthesis inhibition against
bacterial cell wall¹. This phenomenon corresponds
to the action from mechanism of anti-bacterial
potential of certain drugs against bacteria.  Anti-
bacterial that works by inhibition of bacterial cell wall
synthesis is assumed to be influenced by
peptidoglycan synthesis. Here, peptidoglycan is
considered as compound needed to synthesize
Table 4. Summary of the statistical test on various
Lidocaine concentrations as bacteriocidal agent
against Streptococcus mutans.
Concentration % P*
2% - 1% 1.000
2% - 0.5% 0.317
2% - 0.25 % 0.025*
1% - 0.5% 0.317
1% - 0.25% 0.025*
0.5% - 0.25% 0.114
* Significance value based on Mann-Whitney Test
The Kruskal-Wallis analysis on Table 4 indicates that
no difference among various Lidocaine concentration
on its bacteriocidal effect against Streptococcus
mutans (p>0.05).  Thus, conclusion can be drawn that
various Lidocaine concentrations bring no effects on
bacteriocidal potential against Streptococcus mutans.
4. Discussion
Lidocaine-based research against Streptococcus
mutans indicates that 2%, 1% and 0.5% Lidocaine
concentrations bring bacteriostatic effect against
Streptococcus mutans. This finding was proven by
observing the baseline between test concentration
and positive control, as well as negative control. The
positive control serves as bacterial suspension on BHI
Concentration % P*
2 1 0.5 0.25 0.433
* Significance value based on Mann-Whitney Test
38
bacterial wall, which is composed from glucose and
amino acid. The inhibition mechanism of
peptidoglycan synthesis is done by preventing
transport of peptidoglycan monomer synthesis
produced by cytosol passing through cytoplasm
membrane³.
Lidocaine is a local anesthetics agent formed by
combination of weak base and strong base. The agent
can easily be hydrolyzed on cellular tissue which is
later bound by fatty layer on cytoplasm membrane
to produce selective membrane permeability4.
Selectivity of membrane permeability on bacterial
cell will prevent the transport of peptidoglycan
monomer synthesis, which is a composing compound
for bacterial wall. The inhibition of bacterial wall
composer will inhibit the growth of bacterial cell
caused by weakened cellular tissue in cell.
Streptococcus mutans is a Gram-positive bacteria.
Gram-positive germs have multi-layered veiled cells,
which consist of cell wall and cytoplasm membrane.
The wall consists of relations between peptidoglycan,
teichoic acid, polysaccharide and protein. The wall
of Gram-positive bacteria is thicker than that of
Gram-negative with 40: 1 in comparison.  The thick
wall is hydrophobic. Teichoic acid serves as a
connector between membrane and peptidoglycan
which binds with glycerol in the tip of membrane5,6.
Cytoplasm membrane of Gram-positive bacteria
consist of phospolipid bilayer which is hydrophilic on
surface and hydrophobic in core.
The result of the study indicates that Lidocaine at
test concentration has no bactericidal effect against
Streptococcus mutans.  This finding corresponds to
other study¹ which suggests that Lidocaine at tested
concentration gives no bacteriocidal effects to some
pathogenic bacteria generating nosocomial infection.
5. Conclusion
Based on the result of the study, it can be concluded
that: Lidocaine has effects of anti-bacterial potential
against Streptococcus mutans. The antibacterial
potential is shown by bacteriostatic potential at  2%,
1% and 0.5% concentrations and minimum
bacteriostatic potential at 0.5% concentration.
Lidocaine has no minimum bacteriocidal potential
against Streptococcus mutans at tested
concentration.
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